DeepZyme: Learning Deep Representations of Enzymes for Predicting Catalytically-Beneficial Mutations

Project Information

DeepZyme

Grant agreement ID: 897414

DOI 10.3030/897414

Project closed

EC signature date 28 March 2020

Start date 1 January 2021

End date 31 December 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 162 806,40

EU contribution € 162 806,40

Coordinated by

FREIE UNIVERSITAET BERLIN
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties.

Author(s): Tim Hempel; Katarina Elez; Nadine Krüger; Lluís Raich; Jonathan H. Shrimp; Olga Danov; Danny Jonigk; Danny Jonigk; Armin Braun; Min Shen; Matthew D. Hall; Stefan Pöhlmann; Markus Hoffmann; Frank Noé; Frank Noé
Published in: Chemical Science, Issue 1, 2021, ISSN 2041-6520
Publisher: Royal Society of Chemistry
DOI: 10.1039/d1sc01494c